Peregrine Capital Management LLC Acquires 70,782 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Peregrine Capital Management LLC grew its stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 19.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 436,860 shares of the company's stock after buying an additional 70,782 shares during the period. Peregrine Capital Management LLC owned 0.14% of Stevanato Group worth $8,921,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in STVN. Oppenheimer Asset Management Inc. lifted its holdings in Stevanato Group by 7.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,878 shares of the company's stock valued at $283,000 after purchasing an additional 1,004 shares in the last quarter. Truist Financial Corp raised its position in shares of Stevanato Group by 4.2% during the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company's stock valued at $586,000 after purchasing an additional 1,073 shares during the period. US Bancorp DE lifted its stake in shares of Stevanato Group by 17.9% during the 4th quarter. US Bancorp DE now owns 8,527 shares of the company's stock valued at $186,000 after buying an additional 1,295 shares in the last quarter. Advisors Capital Management LLC boosted its holdings in Stevanato Group by 1.0% in the 4th quarter. Advisors Capital Management LLC now owns 170,776 shares of the company's stock worth $3,721,000 after buying an additional 1,735 shares during the period. Finally, Johnson Financial Group Inc. bought a new position in Stevanato Group in the 4th quarter worth $41,000.

Stevanato Group Price Performance

Shares of STVN stock traded up €0.47 ($0.55) during trading hours on Tuesday, hitting €24.90 ($29.29). The stock had a trading volume of 174,100 shares, compared to its average volume of 338,896. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.83 and a quick ratio of 1.26. The stock has a market capitalization of $7.54 billion, a price-to-earnings ratio of 48.82, a PEG ratio of 2.33 and a beta of 0.55. Stevanato Group S.p.A. has a one year low of €17.12 ($20.14) and a one year high of €25.88 ($30.45). The stock's 50-day moving average price is €23.08 and its two-hundred day moving average price is €21.92.

Stevanato Group Increases Dividend

The company also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be paid a $0.0613 dividend. This is an increase from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date of this dividend is Thursday, June 5th. This represents a yield of 0.3%.

Analysts Set New Price Targets

STVN has been the topic of several research analyst reports. Stephens upgraded Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. William Blair reissued an "outperform" rating on shares of Stevanato Group in a report on Monday. Finally, UBS Group cut their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Stevanato Group presently has an average rating of "Moderate Buy" and a consensus price target of €25.70 ($30.24).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.